OCGN
Ocugen Inc
NASDAQ: OCGN · HEALTHCARE · BIOTECHNOLOGY
$1.73
+2.98% today
Updated 2026-04-30
Market cap
$557.42M
P/E ratio
—
P/S ratio
126.31x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$1 – $3
Volume
8.9M
Ocugen Inc (OCGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26000.00 | $8000.00 | — | — | $0.00 | $0.00 | $0.00 | $42620.00 | $43000.00 | $22920.00 | $2.49M | $6.04M | $4.05M | $4.41M |
| Revenue growth (YoY) | — | -69.2% | -100.0% | — | — | — | — | — | +0.9% | -46.7% | +10755.1% | +142.6% | -32.8% | +8.8% |
| Cost of revenue | — | — | — | $1.61M | $1.67M | $1.53M | $49623.00 | $8.09M | $6.35M | $589000.00 | $1.07M | $704000.00 | $1.97M | $2.39M |
| Gross profit | $26000.00 | $8000.00 | — | $-1.61M | $-1.67M | $-1.53M | $-49623.00 | $-8.09M | $-6.31M | $-589000.00 | $-1.07M | $5.33M | $2.09M | $2.02M |
| Gross margin | 100.0% | 100.0% | — | — | — | — | — | -18972.3% | -14676.7% | -2569.8% | -43.1% | 88.3% | 51.5% | 45.9% |
| R&D | $11.94M | $11.95M | $25.86M | $23.24M | $21.58M | $15.57M | $15.63M | $8.09M | $13.35M | $35.11M | $49.76M | $39.57M | $32.13M | $39.75M |
| SG&A | $3.05M | $4.85M | $6.75M | $8.27M | $8.53M | $9.38M | $10.20M | $6.08M | $7.97M | $22.92M | $35.11M | $31.99M | $26.69M | $27.58M |
| Operating income | $-14.97M | $-16.84M | $-32.66M | $-31.82M | $-30.31M | $-24.95M | $-30.11M | $-14.16M | $-21.29M | $-58.03M | $-84.87M | $-65.53M | $-54.76M | $-62.92M |
| Operating margin | -57569.2% | -210562.5% | — | — | — | — | — | -33230.9% | -49500.0% | -253176.3% | -3411.1% | -1085.7% | -1350.4% | -1425.7% |
| EBITDA | $-14.33M | $-16.22M | $-21.92M | $-30.28M | $-11.38M | $-24.88M | $-14.42M | $-14.10M | $-14.18M | $-57.80M | $-84.39M | $-64.83M | $-52.79M | $-60.53M |
| EBITDA margin | -55115.4% | -202737.5% | — | — | — | — | — | -33087.8% | -32983.7% | -252177.1% | -3391.8% | -1074.0% | -1301.8% | -1371.6% |
| EBIT | $-14.97M | $-16.79M | $-22.64M | $-31.89M | $-13.05M | $-26.41M | $-14.47M | $-14.16M | $-14.29M | $-58.03M | $-84.87M | $-65.53M | $-54.76M | $-62.92M |
| Interest expense | $798000.00 | $0.00 | $151000.00 | $133000.00 | $60000.00 | $134000.00 | $163000.00 | $1.77M | $720963.00 | $79000.00 | $3.52M | — | $688000.00 | $5.19M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-16.93M | $-25.71M | $-22.79M | $-32.02M | $-16.21M | $-26.41M | $-8.64M | $-20.24M | $-21.82M | $-58.37M | $-77.83M | $-63.08M | $-54.05M | $-67.85M |
| Net income growth (YoY) | — | -51.8% | +11.4% | -40.5% | +49.4% | -63.0% | +67.3% | -134.2% | -7.8% | -167.5% | -33.4% | +19.0% | +14.3% | -25.5% |
| Profit margin | -65134.6% | -321400.0% | — | — | — | — | — | -47496.5% | -50748.8% | -254646.6% | -3128.4% | -1045.0% | -1333.0% | -1537.4% |